Catch up on news from Wisconsin’s innovation community with these recent headlines:
—ARI Network Services (NASDAQ: ARIS), a Milwaukee-based company that develops e-commerce software for equipment manufacturers and other customers, was acquired for about $140 million by True Wind Capital,... Read more »
Xconomy Seattle was in Disneyland most of this week, where the operative question, voiced by one of the thousands of other kindred spirits hiking through the hot, crowded streets of Adventureland Thursday afternoon was, “What are all these people waiting for?”... Read more »
[Updated, 6/23/17, 6:23 pm, see below.] A Portola Pharmaceuticals drug developed to prevent risky and potentially fatal blood clots in patients who are hospitalized for an extended period of time received FDA approval on Friday.
The FDA approved the... Read more »
San Antonio—A Chinese pharmaceutical company is licensing two experimental drugs from two University of Texas research institutions for an initial $4.5 million upfront payment. The Texas institutions could receive more money if the drugs meet clinical and regulatory goals.
UT Health... Read more »
Houston—Houston entrepreneur Larry Lawson started out his professional life immersed in the groovy melodies of the mid- to late 1960s.
Lawson was part of an East Texas “sunshine pop” band that relocated to Houston as the Clique. One of the... Read more »
Fuzic, the Indianapolis-based marketing tech startup, announced this week that it has closed on a $3 million seed funding round, bringing the total amount of money raised since inception to $3.5 million. Fuzic’s backers include High Alpha, Allos Ventures... Read more »
This story is part of a series on A.I. in healthcare.
Onno Faber was a member of Silicon Valley’s happy breed of tech startup founders when he was diagnosed with a rare genetic condition that can come with dire health... Read more »
All eyes are on the nation’s capital this week, where the Senate released its version of the American Health Care Act (now called the Better Care Reconciliation Act) and the White House worked on an executive order to address drug prices.... Read more »
One of the year’s most closely watched clinical studies could lead to a landmark approval of a gene therapy and throw wide open the debate over how to pay for expensive drugs. The first drips of data have emerged.
Bluebird Bio... Read more »
EnSync Energy Systems, a manufacturer of renewable energy storage and power control products based in the Milwaukee area, saw its stock price fall more than 37 percent on Thursday after the company announced a public stock offering.
Shares in EnSync (NYSE:... Read more »
Eli Lilly (NYSE: LLY) has completed a $90 million expansion of its biotechnology R&D center in San Diego, added new automated synthesis equipment, and plans to build out its next-generation chemistry capabilities here over the next two years.
The new... Read more »
The founder and chairman of Foxconn, a Taiwanese multinational known as a key supplier for Apple (NASDAQ: AAPL) and other digital device makers, said Thursday that Foxconn plans to invest more than $10 billion in an electronics display-making plant in... Read more »
EnerNOC, a 16-year-old energy management software company, has agreed to be acquired by Enel Group, a global power utility company, in an all-cash deal valued at over $300 million.
Enel Group, through its subsidiary Enel Green Power North America, plans to... Read more »